Camurus AB (publ) (STO:CAMX)
Sweden · Delayed Price · Currency is SEK 626.50
+12.00 (1.95%)
Sep 22, 2026, 5:29 PM CET
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 37.28 billion as of September 22, 2026. Its market cap has decreased by -11.25% in one year.
Market Cap
37.28B
Enterprise Value
33.32B
Revenue
2.27B
Ranking
n/a
PE Ratio
55.41
Stock Price
626.50
ChartMarket Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 1.66B to 37.28B, an increase of 2,140.85%. That is a compound annual growth rate of 33.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 37.28B | 1.48% |
| Dec 30, 2025 | 36.74B | 10.34% |
| Dec 30, 2024 | 33.30B | 11.26% |
| Dec 29, 2023 | 29.93B | 113.76% |
| Dec 30, 2022 | 14.00B | 69.32% |
| Dec 30, 2021 | 8.27B | -18.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 28.48B |
| Hansa Biopharma AB | 3.73B |
| Egetis Therapeutics AB | 3.68B |
| Vicore Pharma Holding AB | 2.84B |
| Flerie AB | 1.52B |
| BioInvent International AB | 1.47B |
| Saniona AB | 1.38B |
| Genovis AB (publ.) | 1.35B |